Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by llasorsa
Group name EquipeMY
Item Type Journal Article
Title Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe
Creator Kroese et al.
Author Tiuri E. Kroese
Author Richard van Hillegersberg
Author Sebastian Schoppmann
Author Pieter R. A. J. Deseyne
Author Philippe Nafteux
Author Radka Obermannova
Author Marianne Nordsmark
Author Per Pfeiffer
Author Maria A. Hawkins
Author Elizabeth Smyth
Author Sheraz Markar
Author George B. Hanna
Author Edward Cheong
Author Asif Chaudry
Author Anneli Elme
Author Antoine Adenis
Author Guillaume Piessen
Author Cihan Gani
Author Christiane J. Bruns
Author Markus Moehler
Author Theodore Liakakos
Author John Reynolds
Author Alessio Morganti
Author Riccardo Rosati
Author Carlo Castoro
Author Domenico D'Ugo
Author Franco Roviello
Author Maria Bencivenga
Author Giovanni de Manzoni
Author Paul Jeene
Author Johanna W. van Sandick
Author Christel Muijs
Author Marije Slingerland
Author Grard Nieuwenhuijzen
Author Bas Wijnhoven
Author Laurens V. Beerepoot
Author Piotr Kolodziejczyk
Author Wojciech P. Polkowski
Author Maria Alsina
Author Manuel Pera
Author Tania F. Kanonnikoff
Author Magnus Nilsson
Author Matthias Guckenberger
Author Stefan Monig
Author Dorethea Wagner
Author Lucjan Wyrwicz
Author Maaike Berbee
Author Ines Gockel
Author Florian Lordick
Author Ewen A. Griffiths
Author Marcel Verheij
Author Peter S. N. van Rossum
Author Hanneke W. M. van Laarhoven
Abstract BACKGROUND: Consensus about the definition and treatment of oligometastatic oesophagogastric cancer is lacking. OBJECTIVE: To assess the definition and treatment of oligometastatic oesophagogastric cancer across multidisciplinary tumour boards (MDTs) in Europe. MATERIAL AND METHODS: European expert centers (n = 49) were requested to discuss 15 real-life cases in their MDT with at least a medical, surgical, and radiation oncologist present. The cases varied in terms of location and number of metastases, histology, timing of detection (i.e. synchronous versus metachronous), primary tumour treatment status, and response to systemic therapy. The primary outcome was the agreement in the definition of oligometastatic disease at diagnosis and after systemic therapy. The secondary outcome was the agreement in treatment strategies. Treatment strategies for oligometastatic disease were categorised into upfront local treatment (i.e. metastasectomy or stereotactic radiotherapy), systemic therapy followed by restaging to consider local treatment or systemic therapy alone. The agreement across MDTs was scored to be either absent/poor (<50%), fair (50%-75%), or consensus (?75%). RESULTS: A total of 47 MDTs across 16 countries fully discussed the cases (96%). Oligometastatic disease was considered in patients with 1-2 metastases in either the liver, lung, retroperitoneal lymph nodes, adrenal gland, soft tissue or bone (consensus). At follow-up, oligometastatic disease was considered after a median of 18 weeks of systemic therapy when no progression or progression in size only of the oligometastatic lesion(s) was seen (consensus). If at restaging after a median of 18 weeks of systemic therapy the number of lesions progressed, this was not considered as oligometastatic disease (fair agreement). There was no consensus on treatment strategies for oligometastatic disease. CONCLUSION: A broad consensus on definitions of oligometastatic oesophagogastric cancer was found among MDTs of oesophagogastric cancer expert centres in Europe. However, high practice variability in treatment strategies exists.
Publication European Journal of Cancer (Oxford, England: 1990)
Volume 164
Pages 18-29
Date 2022-03
Journal Abbr Eur J Cancer
Language eng
DOI 10.1016/j.ejca.2021.11.032
ISSN 1879-0852
Library Catalog PubMed
Extra PMID: 35134666
Tags Europe, Gastric neoplasm, Humans, Lymph Nodes, Metastasectomy, Neoplasm Metastasis, Neoplasms, Oesophageal neoplasm, Oligometastasis, Radiosurgery
Date Added 2022/08/30 - 16:36:00
Date Modified 2024/10/10 - 16:33:28
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés